Literature DB >> 28504563

PET Molecular Imaging-Directed Biopsy: A Review.

Baowei Fei1,2,3, David M Schuster1,3.   

Abstract

OBJECTIVE: The purpose of this review is to summarize the applications of PET molecular imaging-directed biopsy of a variety of organs in the management of various diseases with a focus on cancers.
CONCLUSION: PET can yield metabolic information at the cellular and molecular levels, and PET-directed biopsy is playing an increasing role in the diagnosis and staging of diseases.

Entities:  

Keywords:  PET; biopsy; molecular imaging

Mesh：

Substances：

Year:  2017        PMID： 28504563      PMCID： PMC5669368          DOI： 10.2214/AJR.17.18047

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  74 in total

1.  Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?

Authors:  Malik E Juweid; Brian Smith; Emmanuel Itti; Michel Meignan
Journal:  J Clin Oncol       Date:  2010-08-23       Impact factor: 44.544

2.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

3.  Comparison of CT-guided percutaneous biopsy with and without registration of prior PET/CT images to diagnose mediastinal tumors.

Authors:  Koichi Yokoyama; Osamu Ikeda; Koichi Kawanaka; Yutaka Nakasone; Yoshitaka Tamura; Seijiro Inoue; Fumi Sakamoto; Morikatsu Yoshida; Shinya Shiraishi; Yasuyuki Yamashita
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-22       Impact factor: 2.740

4.  Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.

Authors:  Hua Shao; Wen Cheng; Lijuan Yu; Yingci Li; Hui Jing
Journal:  Hepatogastroenterology       Date:  2015-06

5.  First year experience using the Fischer ZD-Neurosurgical Localizing Unit with particular reference to the development of PET-guided stereotactic biopsy.

Authors:  M Levivier; S Goldman; B Pirotte; J Brotchi
Journal:  Acta Neurol Belg       Date:  1993       Impact factor: 2.396

6.  FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.

Authors:  M K Werner; P Aschoff; M Reimold; C Pfannenberg
Journal:  Br J Radiol       Date:  2011-03       Impact factor: 3.039

7.  18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?

Authors:  Nilendu C Purandare; Aniruddha V Kulkarni; Suyash S Kulkarni; Diptiman Roy; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Nucl Med Commun       Date:  2013-03       Impact factor: 1.690

8.  Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.

Authors:  Jeryong Kim; Jinsun Lee; Eilsung Chang; Seongmin Kim; Kwangsun Suh; Jiyoung Sul; Insang Song; Yonghoon Kim; Chuljoo Lee
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

9.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

10.  PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.

Authors:  Wei Guo; Bing Hao; Hao-Jun Chen; Long Zhao; Zuo-Ming Luo; Hua Wu; Long Sun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-22       Impact factor: 9.236
View more
  10 in total

1.  Towards early monitoring of chemotherapy-induced drug resistance based on single cell metabolomics: Combining single-probe mass spectrometry with machine learning.

Authors:  Renmeng Liu; Mei Sun; Genwei Zhang; Yunpeng Lan; Zhibo Yang
Journal:  Anal Chim Acta       Date:  2019-09-25       Impact factor: 6.558

Review 2.  Molecular Imaging in Pediatric Brain Tumors.

Authors:  Agostino Chiaravalloti; Luca Filippi; Maria Ricci; Andrea Cimini; Orazio Schillaci
Journal:  Cancers (Basel)       Date:  2019-11-23       Impact factor: 6.639

3.  Characterization and validation of multimodal annihilation-gamma/near-infrared/visible laparoscopic system.

Authors:  Seong H Song; Han G Kang; Young B Han; Ho-Young Lee; Dae H Jeong; Soo M Kim; Seong J Hong
Journal:  J Biomed Opt       Date:  2019-09       Impact factor: 3.170

4.  KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver.

Authors:  M Popovic; O Talarico; J van den Hoff; H Kunin; Z Zhang; D Lafontaine; S Dogan; J Leung; E Kaye; C Czmielewski; M E Mayerhoefer; P Zanzonico; R Yaeger; H Schöder; J L Humm; S B Solomon; C T Sofocleous; A S Kirov
Journal:  EJNMMI Res       Date:  2020-11-23       Impact factor: 3.138

5.  Concordance of PD-L1 Status Between Image-Guided Percutaneous Biopsies and Matched Surgical Specimen in Non-Small Cell Lung Cancer.

Authors:  Liang Zhao; Peiqiong Chen; Kaili Fu; Jinluan Li; Yaqing Dai; Yuhuan Wang; Yanzhen Zhuang; Long Sun; Haojun Chen; Qin Lin
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

6.  Evaluation of Radiation Exposure to the Patients Undergoing Positron Emission Tomography/Computed Tomography-Guided Biopsies.

Authors:  Krishnapriya Deva; Nivedita Rana; Rajender Kumar; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2022-03-25

7.  Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site.

Authors:  Su Woong Yoo; Md Sunny Anam Chowdhury; Subin Jeon; Sae-Ryung Kang; Changho Lee; Zeenat Jabin; Jahae Kim; Sang-Geon Cho; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Nucl Med Mol Imaging       Date:  2020-07-06

8.  PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice?

Authors:  Min-Hao Wu; Ling-Fei Xiao; Huo-Wen Liu; Zhi-Qiang Yang; Xiao-Xiao Liang; Yan Chen; Jun Lei; Zhou-Ming Deng
Journal:  Cancer Imaging       Date:  2019-10-29       Impact factor: 3.909

9.  Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis.

Authors:  Rachel M Mercer; Charlotte Wigston; Radhika Banka; Giuseppe Cardillo; Rachel Benamore; Andrew G Nicholson; Rachelle Asciak; Maged Hassan; Robert J Hallifax; Louise Wing; Eihab O Bedawi; Nick A Maskell; Elinor K Harriss; Robert F Miller; Najib M Rahman
Journal:  ERJ Open Res       Date:  2020-08-17

Review 10.  Clinical Perspectives for 18F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics.

Authors:  Vassiliki Lyra; Sofia Chatziioannou; Maria Kallergi
Journal:  Metabolites       Date:  2022-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.